{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 8732, "items": [{"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T21:14:38Z", "timestamp": 1525468478024}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JAMA"], "published-print": {"date-parts": [[1993, 1, 27]]}, "DOI": "10.1001/jama.1993.03500040041027", "type": "journal-article", "created": {"date-parts": [[2011, 12, 2]], "date-time": "2011-12-02T07:00:25Z", "timestamp": 1322809225000}, "page": "475", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Antineoplastons: The Controversy Continues"], "prefix": "10.1001", "volume": "269", "author": [{"given": "Stanislaw", "family": "Burzynski", "sequence": "first", "affiliation": []}], "member": "10", "container-title": ["JAMA: The Journal of the American Medical Association"], "language": "en", "link": [{"URL": "http://jamanetwork.com/journals/jama/fullarticle/403001", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T17:28:34Z", "timestamp": 1481822914000}, "score": 30.050156, "issued": {"date-parts": [[1993, 1, 27]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 1, 27]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1001/jama.1993.03500040041027", "ISSN": ["0098-7484"], "issn-type": [{"value": "0098-7484", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T15:28:10Z", "timestamp": 1525793290227}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "suppl 3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuro Oncol"], "published-print": {"date-parts": [[2016, 6]]}, "DOI": "10.1093/neuonc/now069.21", "type": "journal-article", "created": {"date-parts": [[2016, 6, 14]], "date-time": "2016-06-14T18:01:05Z", "timestamp": 1465927265000}, "page": "iii28.4-iii29", "source": "Crossref", "is-referenced-by-count": 0, "title": ["EPT-22TREATMENT OF CHILDREN WITH PRIMARY CNS TUMORS AND LEPTOMENINGEAL, DISSEMINATED AND/OR MULTICENTRIC DISEASE IN PHASE II STUDIES WITH ANTINEOPLASTONS A10 AND AS2-1"], "prefix": "10.1093", "volume": "18", "author": [{"given": "Stanislaw", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory", "family": "Burzynski", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2016, 6, 12]]}, "container-title": ["Neuro-Oncology"], "language": "en", "link": [{"URL": "http://academic.oup.com/neuro-oncology/article-pdf/18/suppl_3/iii28/7501113/now069.21.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 24]], "date-time": "2017-08-24T13:04:34Z", "timestamp": 1503579874000}, "score": 27.569687, "issued": {"date-parts": [[2016, 6]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 6, 12]]}, "published-print": {"date-parts": [[2016, 6]]}, "issue": "suppl 3"}, "alternative-id": ["10.1093/neuonc/now069.21"], "URL": "http://dx.doi.org/10.1093/neuonc/now069.21", "ISSN": ["1522-8517", "1523-5866"], "issn-type": [{"value": "1522-8517", "type": "print"}, {"value": "1523-5866", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T15:30:32Z", "timestamp": 1525361432278}, "reference-count": 65, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 4, 1]], "date-time": "2003-04-01T00:00:00Z", "timestamp": 1049155200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Medical Hypotheses"], "published-print": {"date-parts": [[2003, 4]]}, "DOI": "10.1016/s0306-9877(03)00050-1", "type": "journal-article", "created": {"date-parts": [[2003, 3, 4]], "date-time": "2003-03-04T16:29:22Z", "timestamp": 1046795362000}, "page": "578-583", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Gene silencing \u2013 a new theory of aging"], "prefix": "10.1016", "volume": "60", "author": [{"given": "Stanislaw R", "family": "Burzynski", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Medical Hypotheses"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0306987703000501?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0306987703000501?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 2, 3]], "date-time": "2018-02-03T01:07:10Z", "timestamp": 1517620030000}, "score": 27.422823, "issued": {"date-parts": [[2003, 4]]}, "references-count": 65, "journal-issue": {"published-print": {"date-parts": [[2003, 4]]}, "issue": "4"}, "alternative-id": ["S0306987703000501"], "URL": "http://dx.doi.org/10.1016/s0306-9877(03)00050-1", "ISSN": ["0306-9877"], "issn-type": [{"value": "0306-9877", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T22:43:50Z", "timestamp": 1525733030714}, "reference-count": 0, "publisher": "MedCrave Group, LLC", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JNSK"], "DOI": "10.15406/jnsk.2015.02.00054", "type": "journal-article", "created": {"date-parts": [[2015, 11, 14]], "date-time": "2015-11-14T04:52:06Z", "timestamp": 1447476726000}, "source": "Crossref", "is-referenced-by-count": 3, "title": ["Long-Term Survival (Over 20 Years), Complete Response and Normal Childhood Development in Medulloblastoma Treated with Antineoplastons A10 and AS2-1"], "prefix": "10.15406", "volume": "2", "author": [{"given": "Stanislaw S", "family": "Burzynski", "sequence": "first", "affiliation": []}], "member": "6139", "published-online": {"date-parts": [[2015, 5, 25]]}, "container-title": ["Journal of Neurology & Stroke"], "link": [{"URL": "http://medcraveonline.com/JNSK/JNSK-02-00054.php", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 3, 30]], "date-time": "2018-03-30T12:28:50Z", "timestamp": 1522412930000}, "score": 27.422823, "issued": {"date-parts": [[2015, 5, 25]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 5, 25]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.15406/jnsk.2015.02.00054", "ISSN": ["2373-6410"], "issn-type": [{"value": "2373-6410", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T22:43:52Z", "timestamp": 1525733032121}, "reference-count": 0, "publisher": "MedCrave Group, LLC", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JNSK"], "DOI": "10.15406/jnsk.2015.02.00072", "type": "journal-article", "created": {"date-parts": [[2015, 11, 14]], "date-time": "2015-11-14T05:27:16Z", "timestamp": 1447478836000}, "source": "Crossref", "is-referenced-by-count": 2, "title": ["Long-Term Survival Over 21 Years and Pathologically Confirmed Complete Response in Pediatric Anaplastic Astrocytoma: A Case Report"], "prefix": "10.15406", "volume": "2", "author": [{"given": "Stanislaw R", "family": "Burzynski", "sequence": "first", "affiliation": []}], "member": "6139", "published-online": {"date-parts": [[2015, 9, 10]]}, "container-title": ["Journal of Neurology & Stroke"], "link": [{"URL": "http://medcraveonline.com/JNSK/JNSK-02-00072.php", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 3, 30]], "date-time": "2018-03-30T12:28:57Z", "timestamp": 1522412937000}, "score": 27.422823, "issued": {"date-parts": [[2015, 9, 10]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 9, 10]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.15406/jnsk.2015.02.00072", "ISSN": ["2373-6410"], "issn-type": [{"value": "2373-6410", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T03:40:31Z", "timestamp": 1525405231543}, "reference-count": 63, "publisher": "SAGE Publications", "issue": "1", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2004, 3, 1]], "date-time": "2004-03-01T00:00:00Z", "timestamp": 1078099200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Integr Cancer Ther"], "published-print": {"date-parts": [[2004, 3]]}, "DOI": "10.1177/1534735403261964", "type": "journal-article", "created": {"date-parts": [[2004, 4, 22]], "date-time": "2004-04-22T00:41:30Z", "timestamp": 1082594490000}, "page": "47-58", "source": "Crossref", "is-referenced-by-count": 30, "title": ["The Present State of Antineoplaston Research (1)"], "prefix": "10.1177", "volume": "3", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": [{"name": "Burzynski Research Institute, Houston, TX, "}]}], "member": "179", "published-online": {"date-parts": [[2016, 7, 25]]}, "reference": [{"key": "atypb1", "unstructured": "1. Burzynski SR. Antineoplastons\u2014history of the research (I). Drugs Exptl Clin Res. 1986; 12(suppl 1): 1-9."}, {"key": "atypb2", "DOI": "10.2165/00002512-199507030-00001", "doi-asserted-by": "publisher"}, {"key": "atypb3", "DOI": "10.1007/BF01900774", "doi-asserted-by": "publisher"}, {"key": "atypb4", "unstructured": "4. Burzynski SR. Biologically active peptides in human urine: I. Isolation of a group of medium-sized peptides. Physiol Chemo Phys. 1973; 5: 437-447."}, {"key": "atypb5", "unstructured": "5. Burzynski SR, Ungar AL, Lubanski E. Biologically active peptides in human urine: II. Effect on intestinal smooth muscle and heart. Physiol Chem Phys. 1974; 6: 457-468."}, {"key": "atypb6", "unstructured": "6. Burzynski SR, Loo TL, Ho DH, et al. Biologically active peptides in human urine: III. Inhibitors of the growth of leukemia, osteosarcoma and HeLa cells. Physiol Chem Phys. 1976; 8: 13-22."}, {"key": "atypb7", "unstructured": "7. Burzynski SR. Antineoplastons: biochemical defense against cancer. Physiol Chem Phys. 1976; 8: 275-279."}, {"key": "atypb9", "unstructured": "9. Burzynski SR, Kubove E, Burzynski B. Treatment of hormonally refractory cancer of the prostate with antineoplaston AS2-1. Drugs Exptl Clin Res. 1990; 16: 361-369."}, {"key": "atypb10", "DOI": "10.1016/S0306-9877(03)00050-1", "doi-asserted-by": "publisher"}, {"key": "atypb12", "DOI": "10.1146/annurev.genom.1.1.409", "doi-asserted-by": "publisher"}, {"key": "atypb13", "unstructured": "13. Liau MC, Lee SS, Burzynski SR. Hypomethylation of nucleic acids: a key to the induction of terminal differentiation. Internat J Exptl Clin Chemother. 1989; 2: 187-199."}, {"key": "atypb14", "unstructured": "14. Burzynski SR, Stolzmann Z, Szopa B, et al. Antineoplaston A in cancer therapy (I). Physiol Chem Phys. 1977; 9: 485-500."}, {"key": "atypb15", "unstructured": "15. Gross S, Galicka N, Grabarczyk M, et al. Urinary peptides inhibit DNA synthesis in vitro in certain cultured neoplastic cells. Clin Chem. 1977; 23: 148-149."}, {"key": "atypb16", "unstructured": "16. Beall P, Szopa B, Burzynski SR, et al. Polypeptides that inhibit human breast cancer division. Cancer Biochem Biophys. 1979; 3: 93-96."}, {"key": "atypb17", "unstructured": "17. Lee SS, Mohabbat MO, Burzynski SR. Tissue culture and animal toxicity studies of antineoplaston A2. Drugs Exptl Clin Res. 1984; 10: 607-610."}, {"key": "atypb18", "DOI": "10.1358/dof.1986.011.07.54620", "doi-asserted-by": "publisher"}, {"key": "atypb19", "DOI": "10.1358/dof.1986.011.07.54488", "doi-asserted-by": "publisher"}, {"key": "atypb20", "DOI": "10.1358/dof.1986.011.10.54895", "doi-asserted-by": "publisher"}, {"key": "atypb21", "unstructured": "21. Burzynski SR, Mohabbat MO. Chronic animal toxicity studies of antineoplaston A2. Drugs Exptl Clin Res. 1986; 12(suppl 1): 73-75."}, {"key": "atypb22", "unstructured": "22. Lee SS, Mohabbat MO, Burzynski SR. In vitro cancer growth inhibition and animal toxicity studies of antineoplaston A3. Drugs Exptl Clin Res. 1987; 13(suppl 1): 57-60."}, {"key": "atypb23", "unstructured": "23. Lee SS, Burzynski SR. Tissue culture and animal toxicity studies of antineoplaston A5. Drugs Exptl Clin Res. 1987; 13(suppl 1): 31-35."}, {"key": "atypb24", "unstructured": "24. Burzynski SR, Kubove E. Initial clinical study with antineoplaston A2 injections in cancer patients with five years follow-up. Drugs Exptl Clin Res. 1987; 13(suppl 1): 1-12."}, {"key": "atypb25", "unstructured": "25. Burzynski SR, Kubove E. Phase I clinical studies of antineoplaston A3 injections. Drugs Exptl Clin Res. 1987; 13(suppl 1): 17-29."}, {"key": "atypb26", "unstructured": "26. Burzynski SR, Kubove E. Phase I clinical studies of antineoplaston A5 injections. Drugs Exptl Clin Res. 1987; 13(suppl 1): 37-43."}, {"key": "atypb28", "DOI": "10.1358/dof.1985.010.02.63053", "doi-asserted-by": "publisher"}, {"key": "atypb29", "unstructured": "29. Burzynski SR. Synthetic antineoplastons and analogs. Drugs of the Future. 1986; 11: 679-688."}, {"key": "atypb30", "unstructured": "30. Burzynski SR, Mohabbat MO, Lee SS. Preclinical studies of antineoplaston AS1-1 and antineoplaston AS2-5. Drugs Exptl Clin Res. 1986; 12(suppl 1): 11-16."}, {"key": "atypb31", "DOI": "10.1358/dof.1986.011.05.54308", "doi-asserted-by": "publisher"}, {"key": "atypb32", "DOI": "10.1358/dof.1986.011.05.54310", "doi-asserted-by": "publisher"}, {"key": "atypb33", "unstructured": "33. Burzynski SR. Antineoplaston AS2-5. Annual Drug Data Report. 1986; 8: 319."}, {"key": "atypb34", "unstructured": "34. Burzynski SR, Mohabbat MO, Burzynski B. Animal toxicology studies on oral formulation of antineoplaston A10. Drugs Exptl Clin Res. 1984; 10: 113-118."}, {"key": "atypb36", "unstructured": "36. Burzynski SR, Burzynski B, Mohabbat MO. Toxicology studies of antineoplaston AS 2-1 injections in cancer patients. Drugs Exptl Clin Res. 1986; 12(suppl 1): 25-35."}, {"key": "atypb37", "unstructured": "37. Burzynski SR, Kubove E. Toxicology studies of antineoplaston A10 injections in cancer patients. Drugs Exptl Clin Res. 1986; 12(suppl 1): 47-55."}, {"key": "atypb38", "unstructured": "38. Lehner AF, Burzynski SR, Hendry LB. 3-phenylacetylamino- 2,6-piperidinedione, a naturally-occurring peptide analog with apparent antineoplastic activity may bind to DNA. Drugs Exptl Clin Res. 1986; 12(suppl 1): 57-72."}, {"key": "atypb39", "unstructured": "39. Ashraf AQ, Liau MC, Mohabbat MO, et al. Preclinical studies of antineoplaston A10 injections. Drugs Exptl Clin Res. 1986; 12(suppl 1): 37-45."}, {"key": "atypb40", "unstructured": "40. Ashraf AQ, Liau MC, Kampalath BN, et al. Pharmacokinetic study of radioactive antineoplaston A10 following oral administration in rats. Drugs Exptl Clin Res. 1987; 13(suppl 1): 45-50."}, {"key": "atypb41", "unstructured": "41. Hendry LB, Muldoon TG, Burzynski, SRet al. Stereochemical modeling studies of the interaction of Antineoplaston A10 with DNA. Drugs Exptl Clin Res. 1987; 13(suppl 1): 77-81."}, {"key": "atypb42", "unstructured": "42. Ashraf AQ, Burzynski SR. Comparative study of antineoplaston A10 levels in plasma of healthy people and cancer patients. Adv Exptl Clin Chemother. 1988; 2: 19-28."}, {"key": "atypb43", "unstructured": "43. Ashraf AQ, Kampalath BN, Burzynski SR. Pharmacokinectic analysis of antineoplaston A10 injections following intravenous administration in rats. Adv Exptl Clin Chemother. 1988; 6: 33-39."}, {"key": "atypb44", "unstructured": "44. Burzynski SR, Kubove E, Burzynski B. Phase I clinical studies of oral formulation of antineoplaston AS2-1. Adv Exptl Clin Chemother. 1988; 2: 29-36."}, {"key": "atypb47", "DOI": "10.1093/jnci/84.22.1699", "doi-asserted-by": "publisher"}, {"key": "atypb48", "DOI": "10.4065/74.2.137", "doi-asserted-by": "publisher"}, {"key": "atypb49", "unstructured": "49. Burzynski SR. Efficacy of antineoplastons A10 and AS2-1. Mayo Clin Proc. 1999; 74: 641-642.", "DOI": "10.4065/74.6.641", "doi-asserted-by": "crossref"}, {"key": "atypb50", "DOI": "10.2165/00044011-199918010-00001", "doi-asserted-by": "publisher"}, {"key": "atypb52", "DOI": "10.2165/00126839-200304020-00002", "doi-asserted-by": "publisher"}, {"key": "atypb53", "DOI": "10.1002/ijc.2910630122", "doi-asserted-by": "publisher"}, {"key": "atypb54", "unstructured": "54. Adam L, Crepin M, Savin Cet al. Sodium phenylbutyrate induces growth inhibition and Bcl-2 down-regulation and apoptosis in MCF7 ras cells in vitro and in nude mice. Cancer Res. 1995; 55: 5156-5160."}, {"key": "atypb55", "DOI": "10.1016/0197-0186(91)90182-D", "doi-asserted-by": "publisher"}, {"key": "atypb56", "DOI": "10.1126/science.1065173", "doi-asserted-by": "publisher"}, {"key": "atypb57", "unstructured": "57. Gorospe M, Shack S, Guyton KZ, et al. Up-regulation and functional role of p21 during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate. Cell Growth Differ. 1996; 7: 1609-1615."}, {"key": "atypb59", "unstructured": "59. Kamitani H, Tanjura S, Watanbe K, et al. Histone acetylation may suppress human glioma cell proliferation with p21 and gelsolin are induced. Neuro-Oncology. 2002; 4: 95-101.", "DOI": "10.1093/neuonc/4.2.95", "doi-asserted-by": "crossref"}, {"key": "atypb62", "unstructured": "62. Mahoney DH, Cohen ME, Friedman HS, et al. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. Neuro-Oncology. 2000; 2: 213-220.", "DOI": "10.1093/neuonc/2.4.213", "doi-asserted-by": "crossref"}, {"key": "atypb63", "DOI": "10.1007/BF00151228", "doi-asserted-by": "publisher"}, {"key": "atypb64", "DOI": "10.1002/1097-0142(19930701)72:1<271::AID-CNCR2820720147>3.0.CO;2-K", "doi-asserted-by": "publisher"}, {"key": "atypb65", "DOI": "10.1016/S0360-3016(98)00501-X", "doi-asserted-by": "publisher"}, {"key": "atypb66", "unstructured": "66. Phuphanich S, Selph J, Snodgrass S, et al. Low dose thalidomide and temodar as salvage therapy for recurrent malignant glioma. Neuro-Oncology. 2002; 4: 374."}, {"key": "atypb67", "unstructured": "67. Prados M, Schold SC Jr, Fine HA, et al. A randomized, doubleblind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. Neuro-Oncology. 2003; 5: 96-103.", "DOI": "10.1093/neuonc/5.2.96", "doi-asserted-by": "crossref"}, {"key": "atypb68", "DOI": "10.1007/s10595-002-2503-2", "doi-asserted-by": "publisher"}, {"key": "atypb69", "unstructured": "69. Tsuda H, Sata M, Saitsu H, et al. Antineoplaston AS2-1 for maintenance therapy in liver cancer. Oncol Rep. 1997; 4: 1213-1216.", "DOI": "10.3892/or.4.6.1213", "doi-asserted-by": "crossref"}, {"key": "atypb70", "unstructured": "70. Kumabe T, Tsuda H, Uchida M, et al. Antineoplaston treatment for advanced hepatocellular carcinoma. Oncol Rep. 1998; 5: 1363-1367.", "DOI": "10.3892/or.5.6.1363", "doi-asserted-by": "crossref"}, {"key": "atypb71", "unstructured": "71. Tsuda H, Sata M, Ijuuin H. A novel strategy for remission induction and maintenance in cancer therapy. Oncol Rep. 2002; 9: 65-68.", "DOI": "10.3892/or.9.1.65", "doi-asserted-by": "crossref"}, {"key": "atypb72", "unstructured": "72. Tsuda H, Sata M, Kumabe T, Uchida M, Hara H. The preventive effect of antineoplaston AS2-1 on HCC recurrence. Oncol Rep. 2003; 10: 391-397.", "DOI": "10.3892/or.10.2.391", "doi-asserted-by": "crossref"}, {"key": "atypb73", "unstructured": "73. Richardson MA, Russell NC, Sanders T, et al. Assessment of outcomes at alternative medicine cancer clinics: a feasibility study. J Altern Complement Med. 2001; 7: 19-32.", "DOI": "10.1089/107555301300004501", "doi-asserted-by": "crossref"}], "container-title": ["Integrative Cancer Therapies"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1177/1534735403261964", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1177/1534735403261964", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 1, 2]], "date-time": "2018-01-02T12:26:08Z", "timestamp": 1514895968000}, "score": 27.422823, "issued": {"date-parts": [[2004, 3]]}, "references-count": 63, "journal-issue": {"published-online": {"date-parts": [[2016, 7, 25]]}, "published-print": {"date-parts": [[2004, 3]]}, "issue": "1"}, "alternative-id": ["10.1177/1534735403261964"], "URL": "http://dx.doi.org/10.1177/1534735403261964", "relation": {"cites": []}, "ISSN": ["1534-7354", "1552-695X"], "issn-type": [{"value": "1534-7354", "type": "print"}, {"value": "1552-695X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T02:38:43Z", "timestamp": 1525401523416}, "reference-count": 0, "publisher": "Springer Nature", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs & Aging"], "published-print": {"date-parts": [[1995]]}, "DOI": "10.2165/00002512-199507030-00001", "type": "journal-article", "created": {"date-parts": [[2007, 12, 5]], "date-time": "2007-12-05T11:11:11Z", "timestamp": 1196853071000}, "page": "157-167", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Potential of Antineoplastons in Diseases of Old Age"], "prefix": "10.1007", "volume": "7", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Drugs & Aging"], "language": "en", "deposited": {"date-parts": [[2013, 1, 20]], "date-time": "2013-01-20T14:47:34Z", "timestamp": 1358693254000}, "score": 27.422823, "subtitle": [""], "issued": {"date-parts": [[1995]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.2165/00002512-199507030-00001", "ISSN": ["1170-229X"], "issn-type": [{"value": "1170-229X", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 7, 7]], "date-time": "2018-07-07T19:10:04Z", "timestamp": 1530990604834}, "reference-count": 56, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2005, 1, 1]], "date-time": "2005-01-01T00:00:00Z", "timestamp": 1104537600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Medical Hypotheses"], "published-print": {"date-parts": [[2005, 1]]}, "DOI": "10.1016/j.mehy.2004.06.010", "type": "journal-article", "created": {"date-parts": [[2004, 8, 14]], "date-time": "2004-08-14T14:23:46Z", "timestamp": 1092493426000}, "page": "201-208", "source": "Crossref", "is-referenced-by-count": 34, "title": ["Aging: gene silencing or gene activation?"], "prefix": "10.1016", "volume": "64", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Medical Hypotheses"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0306987704003767?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0306987704003767?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 7, 7]], "date-time": "2018-07-07T18:31:30Z", "timestamp": 1530988290000}, "score": 27.422823, "issued": {"date-parts": [[2005, 1]]}, "references-count": 56, "journal-issue": {"published-print": {"date-parts": [[2005, 1]]}, "issue": "1"}, "alternative-id": ["S0306987704003767"], "URL": "http://dx.doi.org/10.1016/j.mehy.2004.06.010", "ISSN": ["0306-9877"], "issn-type": [{"value": "0306-9877", "type": "print"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2018, 11, 27]], "date-time": "2018-11-27T02:10:25Z", "timestamp": 1543284625085}, "reference-count": 2, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 6, 1]], "date-time": "1999-06-01T00:00:00Z", "timestamp": 928195200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mayo Clinic Proceedings"], "published-print": {"date-parts": [[1999, 6]]}, "DOI": "10.4065/74.6.641", "type": "journal-article", "created": {"date-parts": [[2012, 1, 18]], "date-time": "2012-01-18T16:53:46Z", "timestamp": 1326905626000}, "page": "641", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Efficacy of Antineoplastons A10 and AS2-1"], "prefix": "10.4065", "volume": "74", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Mayo Clinic Proceedings"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0025619611641438?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0025619611641438?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 27]], "date-time": "2018-11-27T01:28:39Z", "timestamp": 1543282119000}, "score": 27.422823, "issued": {"date-parts": [[1999, 6]]}, "references-count": 2, "journal-issue": {"published-print": {"date-parts": [[1999, 6]]}, "issue": "6"}, "alternative-id": ["S0025619611641438"], "URL": "http://dx.doi.org/10.4065/74.6.641", "ISSN": ["0025-6196"], "issn-type": [{"value": "0025-6196", "type": "print"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 1, 10]], "date-time": "2019-01-10T20:10:14Z", "timestamp": 1547151014279}, "reference-count": 139, "publisher": "Springer Nature", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pediatric Drugs"], "published-print": {"date-parts": [[2006]]}, "DOI": "10.2165/00148581-200608030-00003", "type": "journal-article", "created": {"date-parts": [[2006, 6, 19]], "date-time": "2006-06-19T08:24:00Z", "timestamp": 1150705440000}, "page": "167-178", "source": "Crossref", "is-referenced-by-count": 30, "title": ["Treatments for Astrocytic Tumors in Children"], "prefix": "10.1007", "volume": "8", "author": [{"given": "Stanislaw R", "family": "Burzynski", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "R2-3-20060619", "author": "Bleyer", "volume": "15", "first-page": "758", "year": "1999", "journal-title": "Childs Nerv Syst", "DOI": "10.1007/s003810050467", "doi-asserted-by": "crossref"}, {"key": "R5-3-20060619", "author": "Reddy", "volume": "1", "first-page": "137", "year": "2001", "journal-title": "Curr Neurol Neurosci Rep", "DOI": "10.1007/s11910-001-0009-7", "doi-asserted-by": "crossref"}, {"key": "R6-3-20060619", "author": "Zacharoulis", "volume": "4", "first-page": "1005", "year": "2004", "journal-title": "Expert Rev Neurother", "DOI": "10.1586/14737175.4.6.1005", "doi-asserted-by": "crossref"}, {"key": "R8-3-20060619", "author": "Stupp", "volume": "352", "first-page": "987", "year": "2005", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJMoa043330", "doi-asserted-by": "crossref"}, {"key": "R9-3-20060619", "author": "DeAngelis", "volume": "352", "first-page": "1036", "year": "2005", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJMe058010", "doi-asserted-by": "crossref"}, {"key": "R10-3-20060619", "author": "Lashford", "volume": "20", "first-page": "4684", "year": "2002", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2002.08.141", "doi-asserted-by": "crossref"}, {"key": "R11-3-20060619", "author": "Estlin", "volume": "78", "first-page": "652", "year": "1998", "journal-title": "Br J Cancer", "DOI": "10.1038/bjc.1998.555", "doi-asserted-by": "crossref"}, {"key": "R13-3-20060619", "author": "Lau", "volume": "11", "first-page": "283", "year": "2005", "journal-title": "Cancer J", "DOI": "10.1097/00130404-200507000-00004", "doi-asserted-by": "crossref"}, {"key": "R14-3-20060619", "author": "Rubin", "volume": "5", "first-page": "557", "year": "2005", "journal-title": "Nat Rev Cancer", "DOI": "10.1038/nrc1653", "doi-asserted-by": "crossref"}, {"key": "R15-3-20060619", "author": "Pollack", "volume": "331", "first-page": "1500", "year": "1994", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199412013312207", "doi-asserted-by": "crossref"}, {"key": "R16-3-20060619", "author": "Korf", "volume": "1", "first-page": "162", "year": "2001", "journal-title": "Curr Neurol Neurosci Rep", "DOI": "10.1007/s11910-001-0012-z", "doi-asserted-by": "crossref"}, {"key": "R17-3-20060619", "author": "Zizka", "volume": "11", "first-page": "2638", "year": "2001", "journal-title": "Eur Radiol", "DOI": "10.1007/s003300000732", "doi-asserted-by": "crossref"}, {"key": "R18-3-20060619", "author": "Shaw", "volume": "5", "first-page": "153", "year": "2003", "journal-title": "Neuro-oncol", "DOI": "10.1215/S1152851702000601", "doi-asserted-by": "crossref"}, {"key": "R19-3-20060619", "author": "Pollack", "volume": "80", "first-page": "681", "year": "1994", "journal-title": "JNeurosurg"}, {"key": "R20-3-20060619", "author": "Bowers", "volume": "32", "first-page": "24", "year": "2000", "journal-title": "Pediatr Neurosurg", "DOI": "10.1159/000028893", "doi-asserted-by": "crossref"}, {"key": "R21-3-20060619", "author": "Fisher", "volume": "51", "first-page": "704", "year": "2001", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/S0360-3016(01)01705-9", "doi-asserted-by": "crossref"}, {"key": "R22-3-20060619", "author": "Kilic", "volume": "9", "first-page": "549", "year": "2002", "journal-title": "J Clin Neurosci", "DOI": "10.1054/jocn.2002.1136", "doi-asserted-by": "crossref"}, {"key": "R23-3-20060619", "author": "Saran", "volume": "53", "first-page": "43", "year": "2002", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/S0360-3016(02)02734-7", "doi-asserted-by": "crossref"}, {"key": "R24-3-20060619", "author": "Merchant", "volume": "52", "first-page": "325", "year": "2002", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/S0360-3016(01)01807-7", "doi-asserted-by": "crossref"}, {"key": "R25-3-20060619", "author": "Marcus", "volume": "61", "first-page": "374", "year": "2005", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/j.ijrobp.2004.06.012", "doi-asserted-by": "crossref"}, {"key": "R26-3-20060619", "author": "Freeman", "volume": "77", "first-page": "555", "year": "1996", "journal-title": "Cancer", "DOI": "10.1002/(SICI)1097-0142(19960201)77:3<555::AID-CNCR19>3.0.CO;2-3", "doi-asserted-by": "crossref"}, {"key": "R27-3-20060619", "author": "Lesser", "volume": "11", "first-page": "138", "year": "2001", "journal-title": "Semin Radiat Oncol", "DOI": "10.1053/srao.2001.21422", "doi-asserted-by": "crossref"}, {"key": "R28-3-20060619", "author": "Massimino", "volume": "20", "first-page": "4209", "year": "2002", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2002.08.087", "doi-asserted-by": "crossref"}, {"key": "R29-3-20060619", "author": "Rosenstock", "volume": "63", "first-page": "862", "year": "1985", "journal-title": "J Neurosurg", "DOI": "10.3171/jns.1985.63.6.0862", "doi-asserted-by": "crossref"}, {"key": "R30-3-20060619", "author": "Lefkowitz", "volume": "61", "first-page": "896", "year": "1988", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19880301)61:5<896::AID-CNCR2820610507>3.0.CO;2-C", "doi-asserted-by": "crossref"}, {"key": "R31-3-20060619", "author": "Bouffet", "volume": "6", "first-page": "450", "year": "2004", "journal-title": "Neuro-oncol"}, {"key": "R32-3-20060619", "author": "Gururangan", "volume": "6", "first-page": "457", "year": "2004", "journal-title": "Neuro-oncol"}, {"key": "R33-3-20060619", "author": "Quinn", "volume": "21", "first-page": "646", "year": "2003", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2003.01.009", "doi-asserted-by": "crossref"}, {"key": "R34-3-20060619", "author": "Kuo", "volume": "25", "first-page": "372", "year": "2003", "journal-title": "J Pediatr Hematol Oncol", "DOI": "10.1097/00043426-200305000-00005", "doi-asserted-by": "crossref"}, {"key": "R35-3-20060619", "author": "Walter", "volume": "22", "first-page": "247", "year": "2000", "journal-title": "J Pediatr Hematol Oncol", "DOI": "10.1097/00043426-200005000-00010", "doi-asserted-by": "crossref"}, {"key": "R36-3-20060619", "author": "Packer", "volume": "86", "first-page": "747", "year": "1997", "journal-title": "J Neurosurg", "DOI": "10.3171/jns.1997.86.5.0747", "doi-asserted-by": "crossref"}, {"key": "R37-3-20060619", "author": "Pons", "volume": "14", "first-page": "151", "year": "1992", "journal-title": "J Neurooncol", "DOI": "10.1007/BF00177619", "doi-asserted-by": "crossref"}, {"key": "R38-3-20060619", "author": "Petronio", "volume": "74", "first-page": "701", "year": "1991", "journal-title": "J Neurosurg", "DOI": "10.3171/jns.1991.74.5.0701", "doi-asserted-by": "crossref"}, {"key": "R40-3-20060619", "author": "Lafay-Cousin", "volume": "103", "first-page": "2636", "year": "2005", "journal-title": "Cancer", "DOI": "10.1002/cncr.21091", "doi-asserted-by": "crossref"}, {"key": "R42-3-20060619", "author": "Dosoretz", "volume": "45", "first-page": "1467", "year": "1980", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19800315)45:6<1467::AID-CNCR2820450628>3.0.CO;2-#", "doi-asserted-by": "crossref"}, {"key": "R43-3-20060619", "author": "Tenny", "volume": "57", "first-page": "452", "year": "1982", "journal-title": "J Neurosurg", "DOI": "10.3171/jns.1982.57.4.0452", "doi-asserted-by": "crossref"}, {"key": "R44-3-20060619", "author": "Janss", "volume": "75", "first-page": "1051", "year": "1995", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19950215)75:4<1051::AID-CNCR2820750423>3.0.CO;2-S", "doi-asserted-by": "crossref"}, {"key": "R45-3-20060619", "author": "Lewis", "volume": "91", "first-page": "929", "year": "1984", "journal-title": "Ophthalmology", "DOI": "10.1016/S0161-6420(84)34217-8", "doi-asserted-by": "crossref"}, {"key": "R46-3-20060619", "author": "Riccardi", "volume": "22", "first-page": "66", "year": "1992", "journal-title": "Curr Probl Pediatr", "DOI": "10.1016/0045-9380(92)90053-2", "doi-asserted-by": "crossref"}, {"key": "R47-3-20060619", "author": "Wisoff", "volume": "73", "first-page": "661", "year": "1990", "journal-title": "J Neurosurg", "DOI": "10.3171/jns.1990.73.5.0661", "doi-asserted-by": "crossref"}, {"key": "R48-3-20060619", "author": "Grabenbauer", "volume": "54", "first-page": "239", "year": "2000", "journal-title": "Radiother Oncol", "DOI": "10.1016/S0167-8140(00)00149-3", "doi-asserted-by": "crossref"}, {"key": "R49-3-20060619", "author": "Kortmann", "volume": "179", "first-page": "509", "year": "2003", "journal-title": "Strahlenther Onkol", "DOI": "10.1007/s00066-003-9104-9", "doi-asserted-by": "crossref"}, {"key": "R50-3-20060619", "author": "Packer", "volume": "23", "first-page": "79", "year": "1988", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410230113", "doi-asserted-by": "crossref"}, {"key": "R51-3-20060619", "author": "Gnekow", "volume": "216", "first-page": "331", "year": "2004", "journal-title": "Klin Padiatr", "DOI": "10.1055/s-2004-832355", "doi-asserted-by": "crossref"}, {"key": "R54-3-20060619", "author": "Marchese", "volume": "65", "first-page": "2771", "year": "1990", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19900615)65:12<2771::AID-CNCR2820651227>3.0.CO;2-J", "doi-asserted-by": "crossref"}, {"key": "R55-3-20060619", "author": "Conway", "volume": "67", "first-page": "2772", "year": "1991", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19910601)67:11<2772::AID-CNCR2820671110>3.0.CO;2-#", "doi-asserted-by": "crossref"}, {"key": "R56-3-20060619", "author": "Wisoff", "volume": "89", "first-page": "52", "year": "1998", "journal-title": "JNeurosurg"}, {"key": "R57-3-20060619", "author": "Heideman", "volume": "80", "first-page": "497", "year": "1997", "journal-title": "Cancer", "DOI": "10.1002/(SICI)1097-0142(19970801)80:3<497::AID-CNCR18>3.0.CO;2-S", "doi-asserted-by": "crossref"}, {"key": "R58-3-20060619", "author": "Packer", "volume": "74", "first-page": "1827", "year": "1994", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19940915)74:6<1827::AID-CNCR2820740628>3.0.CO;2-Q", "doi-asserted-by": "crossref"}, {"key": "R59-3-20060619", "author": "Hodgson", "volume": "50", "first-page": "929", "year": "2001", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/S0360-3016(01)01518-8", "doi-asserted-by": "crossref"}, {"key": "R60-3-20060619", "author": "Dropcho", "volume": "22", "first-page": "355", "year": "1987", "journal-title": "Ann Neurol", "DOI": "10.1002/ana.410220312", "doi-asserted-by": "crossref"}, {"key": "R61-3-20060619", "author": "Sposto", "volume": "7", "first-page": "165", "year": "1989", "journal-title": "J Neurooncol", "DOI": "10.1007/BF00165101", "doi-asserted-by": "crossref"}, {"key": "R62-3-20060619", "author": "Finlay", "volume": "13", "first-page": "112", "year": "1995", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1995.13.1.112", "doi-asserted-by": "crossref"}, {"key": "R63-3-20060619", "author": "Boyett", "volume": "17", "first-page": "526", "year": "1998", "journal-title": "Proc Soc Clin Oncol"}, {"key": "R64-3-20060619", "author": "Chintagumpala", "volume": "22", "first-page": "159", "year": "1999", "journal-title": "Med Pediatr Oncol"}, {"key": "R66-3-20060619", "author": "Arenson", "volume": "21", "first-page": "325", "year": "1999", "journal-title": "J Pediatr Hematol Oncol", "DOI": "10.1097/00043426-199907000-00085", "doi-asserted-by": "crossref"}, {"key": "R67-3-20060619", "author": "Jakacki", "volume": "44", "first-page": "77", "year": "1999", "journal-title": "JNeurooncol", "DOI": "10.1023/A:1006360222643", "doi-asserted-by": "crossref"}, {"key": "R68-3-20060619", "author": "Huncharek", "volume": "19", "first-page": "3569", "year": "1999", "journal-title": "Anticancer Res"}, {"key": "R69-3-20060619", "author": "Nicholson", "volume": "16", "first-page": "3037", "year": "1998", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1998.16.9.3037", "doi-asserted-by": "crossref"}, {"key": "R70-3-20060619", "author": "Korones", "volume": "6", "first-page": "460", "year": "2004", "journal-title": "Neuro-oncol"}, {"key": "R71-3-20060619", "author": "Broniscer", "volume": "6", "first-page": "385", "year": "2004", "journal-title": "Neuro-oncol"}, {"key": "R72-3-20060619", "author": "Freeman", "volume": "40", "first-page": "265", "year": "1998", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/S0360-3016(97)00572-5", "doi-asserted-by": "crossref"}, {"key": "R73-3-20060619", "author": "Pollack", "volume": "46", "first-page": "1652", "year": "1996", "journal-title": "Neurology", "DOI": "10.1212/WNL.46.6.1652", "doi-asserted-by": "crossref"}, {"key": "R74-3-20060619", "author": "Guillamo", "volume": "14", "first-page": "711", "year": "2001", "journal-title": "Curr Opin Neurol", "DOI": "10.1097/00019052-200112000-00006", "doi-asserted-by": "crossref"}, {"key": "R75-3-20060619", "author": "Cheng", "volume": "30", "first-page": "1284", "year": "1999", "journal-title": "Hum Pathol", "DOI": "10.1016/S0046-8177(99)90057-6", "doi-asserted-by": "crossref"}, {"key": "R76-3-20060619", "author": "Louis", "volume": "52", "first-page": "507", "year": "1993", "journal-title": "J Neuropathol Exp Neurol", "DOI": "10.1097/00005072-199309000-00009", "doi-asserted-by": "crossref"}, {"key": "R77-3-20060619", "author": "Gilbertson", "volume": "9", "first-page": "3620", "year": "2003", "journal-title": "Clin Cancer Res"}, {"key": "R78-3-20060619", "author": "Mandell", "volume": "43", "first-page": "959", "year": "1999", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/S0360-3016(98)00501-X", "doi-asserted-by": "crossref"}, {"key": "R79-3-20060619", "author": "Broniscer", "volume": "9", "first-page": "197", "year": "2004", "journal-title": "Oncologist", "DOI": "10.1634/theoncologist.9-2-197", "doi-asserted-by": "crossref"}, {"key": "R80-3-20060619", "author": "Allen", "volume": "86", "first-page": "1064", "year": "1999", "journal-title": "Cancer", "DOI": "10.1002/(SICI)1097-0142(19990915)86:6<1064::AID-CNCR24>3.0.CO;2-1", "doi-asserted-by": "crossref"}, {"key": "R81-3-20060619", "author": "Freeman", "volume": "15", "first-page": "545", "year": "1999", "journal-title": "Childs Nerv Syst", "DOI": "10.1007/s003810050542", "doi-asserted-by": "crossref"}, {"key": "R82-3-20060619", "author": "Freeman", "volume": "47", "first-page": "561", "year": "2000", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/S0360-3016(00)00471-5", "doi-asserted-by": "crossref"}, {"key": "R83-3-20060619", "author": "Broniscer", "volume": "18", "first-page": "1246", "year": "2000", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2000.18.6.1246", "doi-asserted-by": "crossref"}, {"key": "R84-3-20060619", "author": "Jennings", "volume": "20", "first-page": "3431", "year": "2002", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2002.04.109", "doi-asserted-by": "crossref"}, {"key": "R85-3-20060619", "author": "Massimino", "volume": "5", "first-page": "51", "year": "2003", "journal-title": "Neuro-oncol"}, {"key": "R86-3-20060619", "author": "Broniscer", "volume": "103", "first-page": "133", "year": "2005", "journal-title": "Cancer", "DOI": "10.1002/cncr.20741", "doi-asserted-by": "crossref"}, {"key": "R87-3-20060619", "author": "Bouffet", "volume": "88", "first-page": "685", "year": "2000", "journal-title": "Cancer", "DOI": "10.1002/(SICI)1097-0142(20000201)88:3<685::AID-CNCR27>3.0.CO;2-K", "doi-asserted-by": "crossref"}, {"key": "R88-3-20060619", "author": "Burzynski", "volume": "6", "first-page": "386", "year": "2004", "journal-title": "Neuro-oncol"}, {"key": "R89-3-20060619", "author": "Burzynski", "volume": "7", "first-page": "300", "year": "2005", "journal-title": "Neuro-oncol"}, {"key": "R90-3-20060619", "author": "Burzynski", "volume": "4", "first-page": "91", "year": "2003", "journal-title": "Drugs R D", "DOI": "10.2165/00126839-200304020-00002", "doi-asserted-by": "crossref"}, {"key": "R92-3-20060619", "author": "Sheline", "volume": "6", "first-page": "1215", "year": "1980", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/0360-3016(80)90175-3", "doi-asserted-by": "crossref"}, {"key": "R93-3-20060619", "author": "Nelson", "volume": "25", "first-page": "193", "year": "1993", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/0360-3016(93)90340-2", "doi-asserted-by": "crossref"}, {"key": "R94-3-20060619", "author": "Marks", "volume": "7", "first-page": "243", "year": "1981", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/0360-3016(81)90443-0", "doi-asserted-by": "crossref"}, {"key": "R96-3-20060619", "author": "Lee", "volume": "57", "first-page": "1473", "year": "1986", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19860415)57:8<1473::AID-CNCR2820570807>3.0.CO;2-B", "doi-asserted-by": "crossref"}, {"key": "R98-3-20060619", "author": "Parsons", "volume": "30", "first-page": "755", "year": "1994", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/0360-3016(94)90346-8", "doi-asserted-by": "crossref"}, {"key": "R99-3-20060619", "author": "Goldsmith", "volume": "185", "first-page": "71", "year": "1992", "journal-title": "Radiology", "DOI": "10.1148/radiology.185.1.1523337", "doi-asserted-by": "crossref"}, {"key": "R100-3-20060619", "author": "Cavazzuti", "volume": "53", "first-page": "618", "year": "1980", "journal-title": "J Neurosurg", "DOI": "10.3171/jns.1980.53.5.0618", "doi-asserted-by": "crossref"}, {"key": "R101-3-20060619", "author": "Riva", "volume": "5", "first-page": "107", "year": "1989", "journal-title": "Childs Nerv Syst", "DOI": "10.1007/BF00571120", "doi-asserted-by": "crossref"}, {"key": "R102-3-20060619", "author": "Carpentieri", "volume": "22", "first-page": "236", "year": "1994", "journal-title": "J Clin Child Psychol", "DOI": "10.1207/s15374424jccp2202_10", "doi-asserted-by": "crossref"}, {"key": "R103-3-20060619", "author": "Mostow", "volume": "9", "first-page": "592", "year": "1991", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1991.9.4.592", "doi-asserted-by": "crossref"}, {"key": "R104-3-20060619", "author": "Bloom", "volume": "105", "first-page": "43", "year": "1969", "journal-title": "Am J Roentgenol Radium Ther Nucl Med", "DOI": "10.2214/ajr.105.1.43", "doi-asserted-by": "crossref"}, {"key": "R105-3-20060619", "author": "Shalet", "volume": "15", "first-page": "591", "year": "1986", "journal-title": "Clin Endocrinol Metab", "DOI": "10.1016/S0300-595X(86)80011-1", "doi-asserted-by": "crossref"}, {"key": "R106-3-20060619", "author": "Park", "volume": "58", "first-page": "543", "year": "1983", "journal-title": "J Neurosurg", "DOI": "10.3171/jns.1983.58.4.0543", "doi-asserted-by": "crossref"}, {"key": "R107-3-20060619", "author": "Haider", "volume": "3", "first-page": "205", "year": "1989", "journal-title": "J Pediatr Oncol"}, {"key": "R108-3-20060619", "author": "Oberfield", "volume": "108", "first-page": "219", "year": "1986", "journal-title": "J Pediatr", "DOI": "10.1016/S0022-3476(86)80986-6", "doi-asserted-by": "crossref"}, {"key": "R109-3-20060619", "author": "Rappaport", "volume": "25", "first-page": "561", "year": "1989", "journal-title": "Pediatr Res", "DOI": "10.1203/00006450-198906000-00001", "doi-asserted-by": "crossref"}, {"key": "R111-3-20060619", "author": "Meadows", "volume": "40", "first-page": "1903", "year": "1977", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(197710)40:4+<1903::AID-CNCR2820400822>3.0.CO;2-E", "doi-asserted-by": "crossref"}, {"key": "R112-3-20060619", "author": "Neglia", "volume": "325", "first-page": "1330", "year": "1991", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199111073251902", "doi-asserted-by": "crossref"}, {"key": "R113-3-20060619", "author": "Kingston", "volume": "56", "first-page": "331", "year": "1987", "journal-title": "Br J Cancer", "DOI": "10.1038/bjc.1987.199", "doi-asserted-by": "crossref"}, {"key": "R114-3-20060619", "author": "Hawkins", "volume": "56", "first-page": "339", "year": "1987", "journal-title": "Br J Cancer", "DOI": "10.1038/bjc.1987.200", "doi-asserted-by": "crossref"}, {"key": "R115-3-20060619", "author": "Duffner", "volume": "328", "first-page": "1725", "year": "1993", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199306173282401", "doi-asserted-by": "crossref"}, {"key": "R116-3-20060619", "author": "De Vita", "volume": "25", "first-page": "1876", "year": "1965", "journal-title": "Cancer Res"}, {"key": "R117-3-20060619", "author": "Kumar", "volume": "100", "first-page": "81", "year": "1987", "journal-title": "N Z Med J"}, {"key": "R118-3-20060619", "author": "Calvert", "volume": "19", "first-page": "155", "year": "1992", "journal-title": "Semin Oncol"}, {"key": "R119-3-20060619", "author": "Rivkees", "volume": "259", "first-page": "2123", "year": "1988", "journal-title": "JAMA", "DOI": "10.1001/jama.1988.03720140043031", "doi-asserted-by": "crossref"}, {"key": "R120-3-20060619", "author": "Parvinen", "volume": "30", "first-page": "1", "year": "1979", "journal-title": "Exp Mol Pathol", "DOI": "10.1016/0014-4800(79)90077-7", "doi-asserted-by": "crossref"}, {"key": "R121-3-20060619", "author": "Roth", "volume": "15", "first-page": "345", "year": "1988", "journal-title": "Semin Oncol"}, {"key": "R122-3-20060619", "author": "Clayton", "volume": "17", "first-page": "92", "year": "1989", "journal-title": "Med Pediatr Oncol", "DOI": "10.1002/mpo.2950170204", "doi-asserted-by": "crossref"}, {"key": "R123-3-20060619", "author": "Schilsky", "volume": "71", "first-page": "552", "year": "1981", "journal-title": "Am J Med", "DOI": "10.1016/0002-9343(81)90205-9", "doi-asserted-by": "crossref"}, {"key": "R124-3-20060619", "author": "Goren", "volume": "18", "first-page": "69", "year": "1986", "journal-title": "Cancer Chemother Pharmacol", "DOI": "10.1007/BF00253068", "doi-asserted-by": "crossref"}, {"key": "R125-3-20060619", "author": "Schact", "volume": "14", "first-page": "661", "year": "1978", "journal-title": "Kidney Int"}, {"key": "R126-3-20060619", "author": "Dobyan", "volume": "213", "first-page": "551", "year": "1980", "journal-title": "J Pharmacol Exp Ther"}, {"key": "R127-3-20060619", "author": "Holoye", "volume": "60", "first-page": "1691", "year": "1976", "journal-title": "Cancer Treat Rep"}, {"key": "R128-3-20060619", "author": "Jones", "volume": "29", "first-page": "498", "year": "1972", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(197202)29:2<498::AID-CNCR2820290240>3.0.CO;2-O", "doi-asserted-by": "crossref"}, {"key": "R129-3-20060619", "author": "Garbes", "volume": "14", "first-page": "238", "year": "1986", "journal-title": "Med Pediatr Oncol", "DOI": "10.1002/mpo.2950140411", "doi-asserted-by": "crossref"}, {"key": "R130-3-20060619", "author": "Grimson", "volume": "1", "first-page": "261", "year": "1981", "journal-title": "J Clin Neuroophthalmol", "DOI": "10.3109/01658108109010247", "doi-asserted-by": "crossref"}, {"key": "R131-3-20060619", "author": "Shingleton", "volume": "100", "first-page": "1766", "year": "1982", "journal-title": "Arch Ophthalmol", "DOI": "10.1001/archopht.1982.01030040746007", "doi-asserted-by": "crossref"}, {"key": "R132-3-20060619", "author": "Mahaley Jr", "volume": "3", "first-page": "297", "year": "1986", "journal-title": "J Neurooncol", "DOI": "10.1007/BF00165578", "doi-asserted-by": "crossref"}, {"key": "R133-3-20060619", "author": "Kleinschmidt-DeMasters", "volume": "57", "first-page": "1276", "year": "1986", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19860401)57:7<1276::AID-CNCR2820570703>3.0.CO;2-0", "doi-asserted-by": "crossref"}, {"key": "R134-3-20060619", "author": "Rosenblum", "volume": "7", "first-page": "269", "year": "1989", "journal-title": "J Neurooncol", "DOI": "10.1007/BF00172921", "doi-asserted-by": "crossref"}, {"key": "R135-3-20060619", "author": "Weiss", "volume": "291", "first-page": "127", "year": "1974", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM197407182910305", "doi-asserted-by": "crossref"}, {"key": "R136-3-20060619", "author": "Roca", "volume": "69", "first-page": "149", "year": "1985", "journal-title": "Cancer Treat Rep"}, {"key": "R137-3-20060619", "author": "von Hoff", "volume": "63", "first-page": "1527", "year": "1979", "journal-title": "Cancer Treat Rep"}, {"key": "R138-3-20060619", "author": "Hansen", "volume": "7", "first-page": "1457", "year": "1989", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1989.7.10.1457", "doi-asserted-by": "crossref"}, {"key": "R139-3-20060619", "author": "Grunberg", "volume": "25", "first-page": "62", "year": "1989", "journal-title": "Cancer Chemother Pharmacol", "DOI": "10.1007/BF00694340", "doi-asserted-by": "crossref"}, {"key": "R140-3-20060619", "author": "Schaefer", "volume": "56", "first-page": "1934", "year": "1985", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19851015)56:8<1934::AID-CNCR2820560807>3.0.CO;2-F", "doi-asserted-by": "crossref"}, {"key": "R142-3-20060619", "author": "Greene", "volume": "313", "first-page": "579", "year": "1985", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM198507183130301", "doi-asserted-by": "crossref"}, {"key": "R143-3-20060619", "author": "Cohen", "volume": "60", "first-page": "1257", "year": "1976", "journal-title": "Cancer Treat Rep"}, {"key": "R144-3-20060619", "author": "Pogliani", "volume": "72", "first-page": "184", "year": "1987", "journal-title": "Haematologica"}, {"key": "R145-3-20060619", "author": "Bassett", "volume": "4", "first-page": "614", "year": "1986", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1986.4.4.614", "doi-asserted-by": "crossref"}, {"key": "R146-3-20060619", "author": "Des Guetz", "volume": "1", "first-page": "59", "year": "2006", "journal-title": "Targ Oncol", "DOI": "10.1007/s11523-005-0005-y", "doi-asserted-by": "crossref"}, {"key": "R148-3-20060619", "author": "Zhou", "volume": "7", "first-page": "485", "year": "2005", "journal-title": "Neuro-oncol", "DOI": "10.1215/S1152851704000730", "doi-asserted-by": "crossref"}, {"key": "R149-3-20060619", "author": "Bast Jr", "volume": "351", "first-page": "2865", "year": "2004", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJMe048300", "doi-asserted-by": "crossref"}, {"key": "R150-3-20060619", "author": "Cohen", "volume": "6", "first-page": "451", "year": "2004", "journal-title": "Neuro-oncol"}, {"key": "R151-3-20060619", "author": "Oeffinger", "volume": "54", "first-page": "208", "year": "2004", "journal-title": "CA Cancer J Clin", "DOI": "10.3322/canjclin.54.4.208", "doi-asserted-by": "crossref"}, {"key": "R152-3-20060619", "author": "Bhatia", "volume": "11", "first-page": "340", "year": "2005", "journal-title": "Cancer J", "DOI": "10.1097/00130404-200507000-00010", "doi-asserted-by": "crossref"}, {"key": "R153-3-20060619", "author": "Leibel", "volume": "17", "first-page": "1129", "year": "1989", "journal-title": "Int J Radiat Oncol Biol Phys", "DOI": "10.1016/0360-3016(89)90518-X", "doi-asserted-by": "crossref"}, {"key": "R154-3-20060619", "author": "Wen", "volume": "73", "first-page": "3029", "year": "1994", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19940615)73:12<3029::AID-CNCR2820731222>3.0.CO;2-4", "doi-asserted-by": "crossref"}, {"key": "R155-3-20060619", "author": "Pollack", "volume": "7", "first-page": "348", "year": "2005", "journal-title": "Neuro-oncol"}], "container-title": ["Pediatric Drugs"], "language": "en", "deposited": {"date-parts": [[2019, 1, 10]], "date-time": "2019-01-10T19:40:07Z", "timestamp": 1547149207000}, "score": 27.422823, "subtitle": ["Current and Emerging Strategies"], "issued": {"date-parts": [[2006]]}, "references-count": 139, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.2165/00148581-200608030-00003", "relation": {"cites": []}, "ISSN": ["1174-5878"], "issn-type": [{"value": "1174-5878", "type": "print"}], "subject": ["Pediatrics, Perinatology, and Child Health", "Pharmacology (medical)"]}, {"indexed": {"date-parts": [[2018, 4, 17]], "date-time": "2018-04-17T19:29:42Z", "timestamp": 1523993382308}, "reference-count": 31, "publisher": "Scientific Research Publishing, Inc,", "issue": "12", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCT"], "published-print": {"date-parts": [[2016]]}, "DOI": "10.4236/jct.2016.712083", "type": "journal-article", "created": {"date-parts": [[2016, 11, 4]], "date-time": "2016-11-04T03:19:12Z", "timestamp": 1478229552000}, "page": "837-850", "source": "Crossref", "is-referenced-by-count": 1, "title": ["A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas\u2014Final Report (Protocol BT-13)"], "prefix": "10.4236", "volume": "07", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz J.", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}], "member": "2751", "container-title": ["Journal of Cancer Therapy"], "link": [{"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2016.712083", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://file.scirp.org/xml/71765.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2016.712083", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 11]], "date-time": "2017-07-11T04:50:16Z", "timestamp": 1499748616000}, "score": 24.493696, "issued": {"date-parts": [[2016]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[2016]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.4236/jct.2016.712083", "ISSN": ["2151-1934", "2151-1942"], "issn-type": [{"value": "2151-1934", "type": "print"}, {"value": "2151-1942", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T05:26:08Z", "timestamp": 1525843568031}, "reference-count": 0, "publisher": "Canadian Center of Science and Education", "issue": "2", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2016, 10, 10]], "date-time": "2016-10-10T00:00:00Z", "timestamp": 1476057600000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CCO"], "abstract": "<jats:p>&lt;p class=\"cco-body\"&gt;&lt;span lang=\"EN-GB\"&gt;It is estimated that as many as 30% of patients with primary CNS tumors have leptomeningeal, disseminated, and/or multicentric disease (LDM). These patients respond poorly to conventional therapy. Fifty-seven children with LDM (median age of 7.1 years) were treated in multiple prospective phase II clinical studies of high- and low-grade primary CNS tumors with Antineoplastons A10 and AS2-1 (ANP). Their inclusion in this analysis was based on MRI imaging. Patients with glioblastoma were excluded. The patients received ANP therapy 6 times daily; A10: 8.77 g/kg/d; AS2-1: 0.35 g/kg/d. The response to ANP was monitored by MRIs every 8 weeks. Patients evaluable for efficacy (&lt;em&gt;N &lt;/em&gt;= 40) received 12 or more weeks of ANP or developed progressive disease (PD) before 12 weeks. 10 patients (17.5%) achieved an objective response (OR) with 4 (7%) achieving a complete response (CR) and 6 (10.5%) had a partial response (PR). Stable disease (SD) was maintained in 7 patients (12.3%) and PD developed in 23 patients (40.4%). Survival analysis of the 57 children showed 2- and 5-year overall survival (OS) were both 28% while 10- and 15-year OS were both 26%. One of the patients achieving an OR had atypical teratoid/rhabdoid tumor (AT/RT) while nine had low-grade gliomas (LGGs). Grade 3 and 4 toxicities included hypokalemia (14.0%); fatigue, anemia, hypernatremia and leukopenia (3.5% each); diarrhea, hypertension, joint pain, thrombocytopenia, and somnolence (1.8% each). These findings suggest the need for a single-arm, phase II study of ANP in children with LDM.&lt;/span&gt;&lt;/p&gt;</jats:p>", "DOI": "10.5539/cco.v5n2p38", "type": "journal-article", "created": {"date-parts": [[2016, 10, 11]], "date-time": "2016-10-11T01:34:10Z", "timestamp": 1476149650000}, "page": "38", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Primary CNS Tumors and Leptomeningeal, Disseminated and/or Multicentric Disease in Children Treated in Phase II Studies with Antineoplastons A10 and AS2-1"], "prefix": "10.5539", "volume": "5", "author": [{"given": "Stanislaw", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz J", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory S", "family": "Burzynski", "sequence": "additional", "affiliation": []}], "member": "3486", "published-online": {"date-parts": [[2016, 10, 10]]}, "container-title": ["Cancer and Clinical Oncology"], "link": [{"URL": "http://www.ccsenet.org/journal/index.php/cco/article/viewFile/60541/34176", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2016, 10, 11]], "date-time": "2016-10-11T01:34:12Z", "timestamp": 1476149652000}, "score": 24.493696, "issued": {"date-parts": [[2016, 10, 10]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 7, 18]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.5539/cco.v5n2p38", "ISSN": ["1927-4866", "1927-4858"], "issn-type": [{"value": "1927-4858", "type": "print"}, {"value": "1927-4866", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 9, 27]], "date-time": "2018-09-27T05:02:34Z", "timestamp": 1538024554405}, "reference-count": 66, "publisher": "Scientific Research Publishing, Inc,", "issue": "10", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2014, 1, 1]], "date-time": "2014-01-01T00:00:00Z", "timestamp": 1388534400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCT"], "published-print": {"date-parts": [[2014]]}, "DOI": "10.4236/jct.2014.510101", "type": "journal-article", "created": {"date-parts": [[2014, 9, 10]], "date-time": "2014-09-10T07:16:41Z", "timestamp": 1410333401000}, "page": "957-976", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Recurrent Glioblastoma Multiforme\u2014A Strategy for Long-Term Survival"], "prefix": "10.4236", "volume": "05", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz J.", "family": "Janicki", "sequence": "additional", "affiliation": []}], "member": "2751", "container-title": ["Journal of Cancer Therapy"], "link": [{"URL": "http://www.scirp.org/journal/PaperDownload.aspx?DOI=10.4236/jct.2014.510101", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2014.510101", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2014.510101", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 7]], "date-time": "2017-07-07T09:02:58Z", "timestamp": 1499418178000}, "score": 24.493696, "issued": {"date-parts": [[2014]]}, "references-count": 66, "journal-issue": {"published-print": {"date-parts": [[2014]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.4236/jct.2014.510101", "ISSN": ["2151-1934", "2151-1942"], "issn-type": [{"value": "2151-1934", "type": "print"}, {"value": "2151-1942", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 4, 18]], "date-time": "2018-04-18T01:36:05Z", "timestamp": 1524015365718}, "reference-count": 0, "publisher": "Canadian Center of Science and Education", "issue": "1", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2017, 1, 6]], "date-time": "2017-01-06T00:00:00Z", "timestamp": 1483660800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CCO"], "abstract": "<jats:p>Protocol BT-23, a Phase II study, was performed to determine the efficacy and safety of combination Antineoplaston A10 and Antineoplaston AS2-1 (ANP) in children with an optic pathway glioma (OPG). Sixteen patients (12 males, 4 females) ages 1 to 16 years (median age 4.5 years) were treated. The patients received ANP, by intravenous infusion, six times daily (i.e., every four hours). The length of treatment extended from a minimum of 4.1 weeks to a maximum of 210.0 weeks. The median dosage of A10 was 8.07 g/kg/d while for AS2-1 itwas 0.39 g/kg/d.Patients\u2019 best response to ANP was determined: 12.5% of this patient population achieved a complete response, 18.8% achieved a partial response, and 31.3% maintained stable disease. The median overall survival was 78.5 months (95% CI: 37.6-92.3) while median progression-free survival was 45.4 months (95% CI: 7.1-71.4). ANPwas associated with a12% incidence of Grade 3 and a12% incidence of Grade 4 adverse drug experiences (ADEs). There were no Grade 5 ADEs. Grade 3 ADEs included somnolence and elevated SGOT; Grade 4 ADEsincluded hypernatremia and hypokalemia. Long-term quality of life was excellent with no chronic toxicity identified. Children with an OPG respond very well to ANP with good efficacy and toxicity profiles.\u00a0</jats:p>", "DOI": "10.5539/cco.v6n1p25", "type": "journal-article", "created": {"date-parts": [[2017, 1, 6]], "date-time": "2017-01-06T11:56:15Z", "timestamp": 1483703775000}, "page": "25", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Antineoplastons A10 and AS2-1 in the Treatment of Children with Optic Pathway Glioma: Final Report for Protocol BT-23"], "prefix": "10.5539", "volume": "6", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz J.", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}], "member": "3486", "published-online": {"date-parts": [[2017, 1, 6]]}, "container-title": ["Cancer and Clinical Oncology"], "link": [{"URL": "http://www.ccsenet.org/journal/index.php/cco/article/viewFile/64278/35441", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.ccsenet.org/journal/index.php/cco/article/viewFile/64278/35441", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 28]], "date-time": "2017-04-28T07:56:02Z", "timestamp": 1493366162000}, "score": 24.493696, "issued": {"date-parts": [[2017, 1, 6]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 10, 26]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.5539/cco.v6n1p25", "ISSN": ["1927-4866", "1927-4858"], "issn-type": [{"value": "1927-4858", "type": "print"}, {"value": "1927-4866", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T14:14:10Z", "timestamp": 1525702450132}, "reference-count": 0, "publisher": "Canadian Center of Science and Education", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CCO"], "DOI": "10.5539/cco.v4n2p13", "type": "journal-article", "created": {"date-parts": [[2015, 6, 18]], "date-time": "2015-06-18T02:00:27Z", "timestamp": 1434592827000}, "source": "Crossref", "is-referenced-by-count": 2, "title": ["A Phase II Study of Antineoplastons A10 and AS2-1 Injections in Adult Patients With Recurrent Anaplastic Astrocytoma\u2014Final report (Protocol BT-15)"], "prefix": "10.5539", "volume": "4", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz J.", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}], "member": "3486", "published-online": {"date-parts": [[2015, 6, 17]]}, "container-title": ["Cancer and Clinical Oncology"], "deposited": {"date-parts": [[2015, 8, 4]], "date-time": "2015-08-04T02:51:05Z", "timestamp": 1438656665000}, "score": 24.493696, "issued": {"date-parts": [[2015, 6, 17]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 6, 16]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.5539/cco.v4n2p13", "ISSN": ["1927-4866", "1927-4858"], "issn-type": [{"value": "1927-4858", "type": "print"}, {"value": "1927-4866", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T04:29:46Z", "timestamp": 1525840186520}, "reference-count": 27, "publisher": "Scientific Research Publishing, Inc,", "issue": "10", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2014, 1, 1]], "date-time": "2014-01-01T00:00:00Z", "timestamp": 1388534400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCT"], "published-print": {"date-parts": [[2014]]}, "DOI": "10.4236/jct.2014.510100", "type": "journal-article", "created": {"date-parts": [[2014, 9, 10]], "date-time": "2014-09-10T07:16:41Z", "timestamp": 1410333401000}, "page": "946-956", "source": "Crossref", "is-referenced-by-count": 10, "title": ["A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Recurrent Glioblastoma Multiforme: Final Report (Protocol BT-21)"], "prefix": "10.4236", "volume": "05", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz J.", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}], "member": "2751", "container-title": ["Journal of Cancer Therapy"], "link": [{"URL": "http://www.scirp.org/journal/PaperDownload.aspx?DOI=10.4236/jct.2014.510100", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2014.510100", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2014.510100", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 7]], "date-time": "2017-07-07T09:02:44Z", "timestamp": 1499418164000}, "score": 24.493696, "issued": {"date-parts": [[2014]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[2014]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.4236/jct.2014.510100", "ISSN": ["2151-1934", "2151-1942"], "issn-type": [{"value": "2151-1934", "type": "print"}, {"value": "2151-1942", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T21:30:56Z", "timestamp": 1525728656382}, "reference-count": 0, "publisher": "Canadian Center of Science and Education", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CCO"], "abstract": "<jats:p>Most patients with recurrent glioblastoma (RGBM) die within 6 months regardless of treatment. In phase II studies of Antineoplaston A10 and AS2-1 injections (ANP), our investigators have reported objective responses and long-term survival in RGBM. Using a next-generation sequencing (NGS) based assay of 343 cancer-related genes and introns, comprehensive genomic profiling of tumor tissue obtained from a RGBM patient (who remains alive and well) was performed 11 years after diagnosis and permitted assignment of the patient\u2019s RGBM to the classical subgroup. The most important genomic alterations included amplification of epidermal growth factor receptor (EGFR), cyclin-dependent kinase inhibitor 2A and 2B (CDKN2A/B), loss of phosphatase and tensin homolog (PTEN) and telomerase reverse transcriptase (TERT) mutation. An analysis of the signaling networks and other targets of ANP therapy was recently performed and presented in this publication. Based on our findings, patients with classical RGBM have a reasonable possibility of responding to ANP therapy and experiencing long-term survival. It is proposed that this subgroup of RGBM patients be enrolled in a genomics-driven clinical trial of ANP therapy.</jats:p>", "DOI": "10.5539/cco.v4n2p41", "type": "journal-article", "created": {"date-parts": [[2015, 10, 23]], "date-time": "2015-10-23T02:26:07Z", "timestamp": 1445567167000}, "page": "41", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Comprehensive Genomic Profiling of Recurrent Classic Glioblastoma in a Patient Surviving Eleven Years Following Antineoplaston Therapy"], "prefix": "10.5539", "volume": "4", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz J.", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}], "member": "3486", "published-online": {"date-parts": [[2015, 10, 22]]}, "container-title": ["Cancer and Clinical Oncology"], "link": [{"URL": "http://www.ccsenet.org/journal/index.php/cco/article/viewFile/50091/28910", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.ccsenet.org/journal/index.php/cco/article/viewFile/50091/28910", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 1, 6]], "date-time": "2017-01-06T11:56:15Z", "timestamp": 1483703775000}, "score": 24.493696, "issued": {"date-parts": [[2015, 10, 22]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 6, 16]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.5539/cco.v4n2p41", "ISSN": ["1927-4866", "1927-4858"], "issn-type": [{"value": "1927-4858", "type": "print"}, {"value": "1927-4866", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T23:14:40Z", "timestamp": 1525734880672}, "reference-count": 37, "publisher": "Scientific Research Publishing, Inc,", "issue": "12", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2015, 1, 1]], "date-time": "2015-01-01T00:00:00Z", "timestamp": 1420070400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCT"], "published-print": {"date-parts": [[2015]]}, "DOI": "10.4236/jct.2015.612116", "type": "journal-article", "created": {"date-parts": [[2015, 11, 25]], "date-time": "2015-11-25T06:45:57Z", "timestamp": 1448433957000}, "page": "1063-1074", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors\u2014Final Report (Protocol BT-09)"], "prefix": "10.4236", "volume": "06", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz J.", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}], "member": "2751", "container-title": ["Journal of Cancer Therapy"], "link": [{"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2015.612116", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://file.scirp.org/xml/61444.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2015.612116", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 7]], "date-time": "2017-07-07T10:35:54Z", "timestamp": 1499423754000}, "score": 24.493696, "issued": {"date-parts": [[2015]]}, "references-count": 37, "journal-issue": {"published-print": {"date-parts": [[2015]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.4236/jct.2015.612116", "ISSN": ["2151-1934", "2151-1942"], "issn-type": [{"value": "2151-1934", "type": "print"}, {"value": "2151-1942", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T08:07:54Z", "timestamp": 1525853274687}, "reference-count": 23, "publisher": "Scientific Research Publishing, Inc,", "issue": "01", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2015, 1, 1]], "date-time": "2015-01-01T00:00:00Z", "timestamp": 1420070400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCT"], "published-print": {"date-parts": [[2015]]}, "DOI": "10.4236/jct.2015.61006", "type": "journal-article", "created": {"date-parts": [[2015, 1, 8]], "date-time": "2015-01-08T07:33:24Z", "timestamp": 1420702404000}, "page": "40-44", "source": "Crossref", "is-referenced-by-count": 1, "title": ["A Case of Sustained Objective Response of Recurrent/Progressive Diffuse Intrinsic Pontine Glioma with Phenylbutyrate and Targeted Agents"], "prefix": "10.4236", "volume": "06", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}, {"given": "Sheldon", "family": "Brookman", "sequence": "additional", "affiliation": []}], "member": "2751", "container-title": ["Journal of Cancer Therapy"], "link": [{"URL": "http://file.scirp.org/xml/52985.xml", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2015.61006", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://file.scirp.org/xml/52985.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2015.61006", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 7]], "date-time": "2017-07-07T09:30:24Z", "timestamp": 1499419824000}, "score": 24.493696, "issued": {"date-parts": [[2015]]}, "references-count": 23, "journal-issue": {"published-print": {"date-parts": [[2015]]}, "issue": "01"}, "URL": "http://dx.doi.org/10.4236/jct.2015.61006", "ISSN": ["2151-1934", "2151-1942"], "issn-type": [{"value": "2151-1934", "type": "print"}, {"value": "2151-1942", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T09:53:21Z", "timestamp": 1525859601924}, "reference-count": 0, "publisher": "Canadian Center of Science and Education", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CCO"], "DOI": "10.5539/cco.v4n1p28", "type": "journal-article", "created": {"date-parts": [[2015, 3, 16]], "date-time": "2015-03-16T02:06:37Z", "timestamp": 1426471597000}, "source": "Crossref", "is-referenced-by-count": 2, "title": ["A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Newly-Diagnosed Anaplastic Astrocytoma-Final Report (Protocol BT-08)"], "prefix": "10.5539", "volume": "4", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}, {"given": "Ania", "family": "Marszalek", "sequence": "additional", "affiliation": []}], "member": "3486", "published-online": {"date-parts": [[2015, 3, 15]]}, "container-title": ["Cancer and Clinical Oncology"], "deposited": {"date-parts": [[2015, 5, 22]], "date-time": "2015-05-22T01:53:52Z", "timestamp": 1432259632000}, "score": 24.493696, "issued": {"date-parts": [[2015, 3, 15]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 11, 26]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.5539/cco.v4n1p28", "ISSN": ["1927-4866", "1927-4858"], "issn-type": [{"value": "1927-4858", "type": "print"}, {"value": "1927-4866", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T17:14:47Z", "timestamp": 1525454087606}, "reference-count": 24, "publisher": "Scientific Research Publishing, Inc,", "issue": "04", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2011, 1, 1]], "date-time": "2011-01-01T00:00:00Z", "timestamp": 1293840000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCT"], "published-print": {"date-parts": [[2011]]}, "DOI": "10.4236/jct.2011.24071", "type": "journal-article", "created": {"date-parts": [[2011, 10, 31]], "date-time": "2011-10-31T06:09:22Z", "timestamp": 1320041362000}, "page": "518-522", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Treatment of Esthesioneuroblastoma and Nonsmall Cell Lung Cancer with Phenylbutyrate"], "prefix": "10.4236", "volume": "02", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Eva", "family": "Nagy-Kubove", "sequence": "additional", "affiliation": []}], "member": "2751", "container-title": ["Journal of Cancer Therapy"], "link": [{"URL": "http://www.scirp.org/journal/PaperDownload.aspx?DOI=10.4236/jct.2011.24071", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2011.24071", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://file.scirp.org/xml/7795.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2011.24071", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 7]], "date-time": "2017-07-07T05:04:16Z", "timestamp": 1499403856000}, "score": 23.065804, "issued": {"date-parts": [[2011]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[2011]]}, "issue": "04"}, "URL": "http://dx.doi.org/10.4236/jct.2011.24071", "ISSN": ["2151-1934", "2151-1942"], "issn-type": [{"value": "2151-1934", "type": "print"}, {"value": "2151-1942", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T04:19:39Z", "timestamp": 1525839579696}, "reference-count": 60, "publisher": "Scientific Research Publishing, Inc,", "issue": "10", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2014, 1, 1]], "date-time": "2014-01-01T00:00:00Z", "timestamp": 1388534400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCT"], "published-print": {"date-parts": [[2014]]}, "DOI": "10.4236/jct.2014.510099", "type": "journal-article", "created": {"date-parts": [[2014, 9, 4]], "date-time": "2014-09-04T17:25:22Z", "timestamp": 1409851522000}, "page": "929-945", "source": "Crossref", "is-referenced-by-count": 9, "title": ["The Effect of Antineoplastons A10 and AS2-1 and Metabolites of Sodium Phenylbutyrate on Gene Expression in Glioblastoma  Multiforme"], "prefix": "10.4236", "volume": "05", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Sonali S.", "family": "Patil", "sequence": "additional", "affiliation": []}], "member": "2751", "container-title": ["Journal of Cancer Therapy"], "link": [{"URL": "http://www.scirp.org/journal/PaperDownload.aspx?DOI=10.4236/jct.2014.510099", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2014.510099", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2014.510099", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 7]], "date-time": "2017-07-07T09:03:29Z", "timestamp": 1499418209000}, "score": 23.065804, "issued": {"date-parts": [[2014]]}, "references-count": 60, "journal-issue": {"published-print": {"date-parts": [[2014]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.4236/jct.2014.510099", "ISSN": ["2151-1934", "2151-1942"], "issn-type": [{"value": "2151-1934", "type": "print"}, {"value": "2151-1942", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T07:53:39Z", "timestamp": 1525852419547}, "reference-count": 23, "publisher": "Scientific Research Publishing, Inc,", "issue": "14", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2014, 1, 1]], "date-time": "2014-01-01T00:00:00Z", "timestamp": 1388534400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCT"], "published-print": {"date-parts": [[2014]]}, "DOI": "10.4236/jct.2014.514144", "type": "journal-article", "created": {"date-parts": [[2014, 12, 25]], "date-time": "2014-12-25T03:29:00Z", "timestamp": 1419478140000}, "page": "1423-1437", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Preliminary Findings on the Use of Targeted Therapy with Pazopanib and Other Agents in Combination with Sodium Phenylbutyrate in the Treatment of Glioblastoma Multiforme"], "prefix": "10.4236", "volume": "05", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz J.", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}, {"given": "Sheldon", "family": "Brookman", "sequence": "additional", "affiliation": []}], "member": "2751", "container-title": ["Journal of Cancer Therapy"], "link": [{"URL": "http://file.scirp.org/xml/52600.xml", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2014.514144", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://file.scirp.org/xml/52600.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2014.514144", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 7]], "date-time": "2017-07-07T09:32:47Z", "timestamp": 1499419967000}, "score": 20.351309, "issued": {"date-parts": [[2014]]}, "references-count": 23, "journal-issue": {"published-print": {"date-parts": [[2014]]}, "issue": "14"}, "URL": "http://dx.doi.org/10.4236/jct.2014.514144", "ISSN": ["2151-1934", "2151-1942"], "issn-type": [{"value": "2151-1934", "type": "print"}, {"value": "2151-1942", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 4, 14]], "date-time": "2018-04-14T11:00:34Z", "timestamp": 1523703634598}, "reference-count": 63, "publisher": "Scientific Research Publishing, Inc,", "issue": "13", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2014, 1, 1]], "date-time": "2014-01-01T00:00:00Z", "timestamp": 1388534400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCT"], "published-print": {"date-parts": [[2014]]}, "DOI": "10.4236/jct.2014.513128", "type": "journal-article", "created": {"date-parts": [[2014, 11, 20]], "date-time": "2014-11-20T07:09:03Z", "timestamp": 1416467343000}, "page": "1270-1288", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium  Phenylbutyrate in Colorectal Cancer after Failure of Second-Line Therapy\u2014A Potential Strategy for Improved Survival"], "prefix": "10.4236", "volume": "05", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz J.", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}, {"given": "Sheldon", "family": "Brookman", "sequence": "additional", "affiliation": []}], "member": "2751", "container-title": ["Journal of Cancer Therapy"], "link": [{"URL": "http://file.scirp.org/xml/JCT_2014112013092658.xml", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2014.513128", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://file.scirp.org/xml/JCT_2014112013092658.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jct.2014.513128", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 7]], "date-time": "2017-07-07T09:31:17Z", "timestamp": 1499419877000}, "score": 20.351309, "issued": {"date-parts": [[2014]]}, "references-count": 63, "journal-issue": {"published-print": {"date-parts": [[2014]]}, "issue": "13"}, "URL": "http://dx.doi.org/10.4236/jct.2014.513128", "ISSN": ["2151-1934", "2151-1942"], "issn-type": [{"value": "2151-1934", "type": "print"}, {"value": "2151-1942", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 7, 27]], "date-time": "2018-07-27T14:11:02Z", "timestamp": 1532700662371}, "reference-count": 36, "publisher": "Springer Nature", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Childs Nerv Syst"], "published-print": {"date-parts": [[2014, 12]]}, "DOI": "10.1007/s00381-014-2401-z", "type": "journal-article", "created": {"date-parts": [[2014, 4, 9]], "date-time": "2014-04-09T08:17:24Z", "timestamp": 1397031444000}, "page": "2051-2061", "source": "Crossref", "is-referenced-by-count": 12, "title": ["The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma"], "prefix": "10.1007", "volume": "30", "author": [{"given": "Stanislaw R.", "family": "Burzynski", "sequence": "first", "affiliation": []}, {"given": "Tomasz J.", "family": "Janicki", "sequence": "additional", "affiliation": []}, {"given": "Gregory S.", "family": "Burzynski", "sequence": "additional", "affiliation": []}, {"given": "Ania", "family": "Marszalek", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 4, 10]]}, "reference": [{"key": "2401_CR1", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1016/S1470-2045(06)70615-5", "volume": "7", "author": "D Hargrave", "year": "2006", "unstructured": "Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet 7:241\u2013248", "journal-title": "Lancet"}, {"key": "2401_CR2", "unstructured": "CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009 (2012). Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, IL, 14:201. http://neuro-oncology.oxfordjournals.org/content/14/suppl_5/v1.extract"}, {"key": "2401_CR3", "first-page": "379", "volume": "5", "author": "SR Burzynski", "year": "2007", "unstructured": "Burzynski SR (2007) Recent clinical trials in diffuse intrinsic brainstem glioma. Cancer Ther 5:379\u2013390", "journal-title": "Cancer Ther"}, {"key": "2401_CR4", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1007/s00401-012-0998-0", "volume": "124", "author": "D-A Khuong-Quang", "year": "2012", "unstructured": "Khuong-Quang D-A, Buczkowicz P, Rakopoulos P, Liu X-Y, Fontebasso AM et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124:439\u2013447", "journal-title": "Acta Neuropathol"}, {"key": "2401_CR5", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1177/1534735403261964", "volume": "3", "author": "SR Burzynski", "year": "2004", "unstructured": "Burzynski SR (2004) The present state of antineoplaston research (1). Integr Cancer Ther 3:47\u201358", "journal-title": "Integr Cancer Ther"}, {"key": "2401_CR6", "author": "SR Burzynski", "year": "2006", "unstructured": "Burzynski SR (2006) Targeted therapy for brain tumors. In: Yang A (ed) Brain cancer: therapy and surgical interventions. Nova Science Publishers, New York", "volume-title": "Brain cancer: therapy and surgical interventions"}, {"key": "2401_CR7", "doi-asserted-by": "crossref", "first-page": "192", "DOI": "10.4236/jct.2012.33028", "volume": "3", "author": "SS Patil", "year": "2012", "unstructured": "Patil SS, Burzynski SR, Mrowczynski E, Grela K, Chittur S (2012) Phenylacetylglutaminate in combination with phenylacetate causes cell cycle blockade and apoptosis by upregulating VDUP1 in U-87 glioblastoma cells. J Cancer Ther 3:192\u2013200", "journal-title": "J Cancer Ther"}, {"key": "2401_CR8", "doi-asserted-by": "crossref", "first-page": "4035", "DOI": "10.1038/sj.onc.1206610", "volume": "22", "author": "SH Han", "year": "2003", "unstructured": "Han SH, Jeon JH, Ju HR, Jung U, Kim KY, Yoo HS, Lee YH, Song KS, Hwang HM, Na YS, Yang Y, Lee KN, Choi I (2003) VDUP1 upregulated by TGF-\u03b21 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22:4035\u20134046", "journal-title": "Oncogene"}, {"key": "2401_CR9", "doi-asserted-by": "crossref", "first-page": "3921", "DOI": "10.1073/pnas.0800293105", "volume": "105", "author": "STY Hui", "year": "2008", "unstructured": "Hui STY, Andres AM, Miller AK, Spann NJ, Potter DW, Post NM, Chen AZ, Sachithanantham S, Jung DY, Kim JK, Davis RA (2008) Txnip balances metabolic and growth signaling via PTEN disulfide reduction. PNAS 105:3921\u20133926", "journal-title": "PNAS"}, {"key": "2401_CR10", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1093/neuonc/nop026", "volume": "12", "author": "H Mure", "year": "2010", "unstructured": "Mure H, Matsuzaki K, Kitazato KT, Mizobuchi Y, Kuwayama K, Kageji T, Nagahiro S (2010) Akt2 and Akt3 play a pivotal role in malignant gliomas. Neuro-Oncol 12:221\u2013232", "journal-title": "Neuro-Oncol"}, {"key": "2401_CR11", "doi-asserted-by": "crossref", "first-page": "1473", "DOI": "10.1038/sj.cdd.4401723", "volume": "12", "author": "AP Gilmore", "year": "2005", "unstructured": "Gilmore AP (2005) Anoikis. Cell Death Differ 12:1473\u20131477", "journal-title": "Cell Death Differ"}, {"key": "2401_CR12", "first-page": "16", "volume": "2", "author": "BB Zhou", "year": "2003", "unstructured": "Zhou BB, Anderson HJ, Roberge M (2003) Targeting DNA checkpoint kinases in cancer therapy. Cancer Biol Ther 2:16\u201322", "journal-title": "Cancer Biol Ther"}, {"issue": "5442", "key": "2401_CR13", "doi-asserted-by": "crossref", "first-page": "1166", "DOI": "10.1126/science.286.5442.1166", "volume": "286", "author": "Y Sanchez", "year": "1999", "unstructured": "Sanchez Y, Bachant J, Wang H, Hu F, Liu D, Tetzlaff M et al (1999) Control of the DNA damage checkpoint by Chk1 and Rad53 protein kinases through distinct mechanisms. Science 286(5442):1166\u20131171", "journal-title": "Science"}, {"key": "2401_CR14", "doi-asserted-by": "crossref", "first-page": "1834", "DOI": "10.1158/0008-5472.CAN-07-5656", "volume": "68", "author": "VL Gabai", "year": "2008", "unstructured": "Gabai VL, O\u2019Callaghan-Sunol C, Meng L, Sherman MY, Yaglom J (2008) Triggering senescence programs suppresses Chk1 kinase and sensitizes cells to genotoxic stresses. Cancer Res 68:1834\u20131842", "journal-title": "Cancer Res"}, {"key": "2401_CR15", "doi-asserted-by": "crossref", "first-page": "ii87", "DOI": "10.1093/neuonc/nop017", "volume": "12", "author": "S Patil", "year": "2010", "unstructured": "Patil S, Burzynski SR, Mrowczynski E, Grela K (2010) Antineoplastons initiate caspase induced apoptosis by suppressing survivin expression in U87 glioblastoma cells. Neuro-Oncol 12:ii87", "journal-title": "Neuro-Oncol"}, {"key": "2401_CR16", "first-page": "iv10", "volume": "12", "author": "S Patil", "year": "2010", "unstructured": "Patil S, Burzynski SR, Mrowczynski E, Grela K (2010) CB-15. Targeting microRNAs in glioma cells with antineoplastons. Neuro-Oncol 12:iv10", "journal-title": "Neuro-Oncol"}, {"key": "2401_CR17", "doi-asserted-by": "crossref", "first-page": "3999", "DOI": "10.1200/JCO.2011.35.5677", "volume": "29", "author": "BS Paugh", "year": "2011", "unstructured": "Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, Olson JM, Geyer JR, Chi SN, Saba da Silva N, Onar-Thomas A, Baker JN, Gajjar A, Ellison DW, Baker SJ (2011) Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29:3999\u20134006", "journal-title": "J Clin Oncol"}, {"key": "2401_CR18", "first-page": "3620", "volume": "9", "author": "RJ Gilbertson", "year": "2003", "unstructured": "Gilbertson RJ, Hill DA, Hernan R, Kocak M, Geyer R, Olson J, Gaijar A, Rush L, Hamilton RL, Finkelstein SD, Pollack IF (2003) ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res 9:3620\u20133624", "journal-title": "Clin Cancer Res"}, {"key": "2401_CR19", "first-page": "47", "volume": "12", "author": "SR Burzynski", "year": "1986", "unstructured": "Burzynski SR, Kubove E (1986) Toxicology studies on antineoplaston A10 injections in cancer patients. Drugs Exp Clin Res 12:47\u201355", "journal-title": "Drugs Exp Clin Res"}, {"key": "2401_CR20", "author": "SR Burzynski", "year": "1992", "unstructured": "Burzynski SR, Kubove E, Burzynski B (1992) Phase II clinical trials of antineoplastons A10 and AS2-1 infusions in astrocytoma. In: Adam D (ed) Recent advances in chemotherapy. Futuramed Publishers, Munich", "volume-title": "Recent advances in chemotherapy"}, {"key": "2401_CR21", "doi-asserted-by": "crossref", "first-page": "1699", "DOI": "10.1093/jnci/84.22.1699", "volume": "84", "author": "MG Hawkins", "year": "1992", "unstructured": "Hawkins MG, Friedman MA (1992) National Cancer Institute\u2019s evaluation of unconventional cancer treatments. J Natl Cancer Inst 84:1699", "journal-title": "J Natl Cancer Inst"}, {"key": "2401_CR22", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.2165/00044011-199918010-00001", "volume": "18", "author": "SR Burzynski", "year": "1999", "unstructured": "Burzynski SR, Conde AB, Peters A, Saling B, Ellithorpe R, Daugherty JP, Nacht CH (1999) A retrospective study of antineoplastons A10 and AS2-1 in primary brain tumours. Clin Drug Investig 18:1\u201310", "journal-title": "Clin Drug Investig"}, {"key": "2401_CR23", "unstructured": "Burzynski SR, Janicki TJ, Burzynski GS, Marszalek A (2014) Long term survival (>13\u00a0years) in a child with recurrent diffuse pontine gliosarcoma: a case report. J Pediatr Hematol Oncol. doi: 10.1097/MPH.0000000000000020", "DOI": "10.1097/MPH.0000000000000020", "doi-asserted-by": "crossref"}, {"key": "2401_CR24", "doi-asserted-by": "crossref", "first-page": "1414", "DOI": "10.1002/1097-0142(19930815)72:4<1414::AID-CNCR2820720442>3.0.CO;2-C", "volume": "72", "author": "RJ Packer", "year": "1993", "unstructured": "Packer RJ, Boyett JM, Zimmerman RA et al (1993) Hyperfractionated radiation therapy (72\u00a0Gy) for children with brain stem gliomas. A Children\u2019s Cancer Group Phase I/II Trial. Cancer 72:1414\u20131421", "journal-title": "Cancer"}, {"key": "2401_CR25", "doi-asserted-by": "crossref", "first-page": "1026", "DOI": "10.1227/00006123-199312000-00010", "volume": "33", "author": "AL Albright", "year": "1993", "unstructured": "Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD (1993) Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children\u2019s Cancer Group. Neurosurgery 33:1026\u20131030", "journal-title": "Neurosurgery"}, {"key": "2401_CR26", "doi-asserted-by": "crossref", "first-page": "1963", "DOI": "10.1200/JCO.2009.26.3541", "volume": "28", "author": "PY Wen", "year": "2010", "unstructured": "Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in Neuro-oncology Working Group. J Clin Oncol 28:1963\u20131972", "journal-title": "J Clin Oncol"}, {"key": "2401_CR27", "first-page": "984", "volume": "17", "author": "SM Chang", "year": "1999", "unstructured": "Chang SM et al (1999) Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol 17:984\u2013990", "journal-title": "J Clin Oncol"}, {"key": "2401_CR28", "doi-asserted-by": "crossref", "first-page": "4", "DOI": "10.1093/neuonc/nos273", "volume": "15", "author": "M Weller", "year": "2013", "unstructured": "Weller M, Cloughesy T, Perry JR, Wick W (2013) Standards of care for treatment of recurrent glioblastoma\u2014are we there yet? Neuro Oncol 15:4\u201327", "journal-title": "Neuro Oncol"}, {"key": "2401_CR29", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.2165/00148581-200608030-00003", "volume": "8", "author": "SR Burzynski", "year": "2006", "unstructured": "Burzynski SR (2006) Treatments for astrocytic tumors in children: current and emerging strategies. Pediatr Drugs 8:167\u2013168", "journal-title": "Pediatr Drugs"}, {"key": "2401_CR30", "doi-asserted-by": "crossref", "first-page": "4684", "DOI": "10.1200/JCO.2002.08.141", "volume": "20", "author": "LS Lashford", "year": "2002", "unstructured": "Lashford LS, Thiesse P, Jouvet A, Jaspan T, Couanet D et al (2002) Temozolomide in malignant gliomas of childhood: a United Kingdom Children\u2019s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 20:4684\u20134691", "journal-title": "J Clin Oncol"}, {"key": "2401_CR31", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1215/S115285170200056X", "volume": "5", "author": "ZE Dreyer", "year": "2003", "unstructured": "Dreyer ZE, Kadota RP, Stewart CF, Friedman HS, Mahoney DH et al (2003) Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237. Neuro Oncol 5:261\u2013267", "journal-title": "Neuro Oncol"}, {"key": "2401_CR32", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1007/s00280-005-0172-7", "volume": "58", "author": "K Warren", "year": "2006", "unstructured": "Warren K, Jakacki R, Widemann B, Aikin A, Libucha M et al (2006) Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children\u2019s Oncology Group. Cancer Chemother Pharmacol 58:343\u2013347", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "2401_CR33", "doi-asserted-by": "crossref", "first-page": "2535", "DOI": "10.1002/cncr.23078", "volume": "110", "author": "M Fouladi", "year": "2007", "unstructured": "Fouladi M, Nicholson HS, Zhou T, Laningham F, Helton KJ et al (2007) A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children\u2019s Oncology Group study. Cancer 110:2535\u20132541", "journal-title": "Cancer"}, {"issue": "28", "key": "2401_CR34", "doi-asserted-by": "crossref", "first-page": "3069", "DOI": "10.1200/JCO.2009.26.8789", "volume": "2010", "author": "S Gururangan", "year": "2010", "unstructured": "Gururangan S, Chi SN, Young Poussaint T, Onar-Thomas A, Gilbertson RJ et al (2010) Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. J Clin Oncol 2010(28):3069\u20133075", "journal-title": "J Clin Oncol"}, {"key": "2401_CR35", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1002/pbc.22690", "volume": "56", "author": "JE Minturn", "year": "2011", "unstructured": "Minturn JE, Janss AJ, Fisher PG, Allen JC, Patti R et al (2011) A phase II study of metronomic oral topotecan for recurrent childhood brain tumors. Pediatr Blood Cancer 56:39\u201344", "journal-title": "Pediatr Blood Cancer"}, {"key": "2401_CR36", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1007/s11060-011-0709-z", "volume": "106", "author": "KE Warren", "year": "2012", "unstructured": "Warren KE, Gururangan S, Geyer JR, McLendon RE, Poussaint TY et al (2012) A phase II study of 06-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain tumor Consortium study. J Neurooncol 106:643\u2013649", "journal-title": "J Neurooncol"}], "container-title": ["Child's Nervous System"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00381-014-2401-z", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 27]], "date-time": "2018-07-27T13:42:41Z", "timestamp": 1532698961000}, "score": 20.351309, "issued": {"date-parts": [[2014, 4, 10]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2014, 12]]}, "issue": "12"}, "alternative-id": ["2401"], "URL": "http://dx.doi.org/10.1007/s00381-014-2401-z", "relation": {"cites": []}, "ISSN": ["0256-7040", "1433-0350"], "issn-type": [{"value": "0256-7040", "type": "print"}, {"value": "1433-0350", "type": "electronic"}], "subject": ["Pediatrics, Perinatology, and Child Health", "Clinical Neurology", "General Medicine"]}], "items-per-page": 25, "query": {"start-index": 0, "search-terms": null}}, "custom_name_alias": "BURZYNSKI STANISLAW"}